logo

DermNet NZ

Invitation to complete melanoma survey

Facts about the skin from DermNet New Zealand Trust. Topic index: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



Basal cell carcinoma

Basal cell carcinoma (BCC) is a common, locally invasive, keratinocytic, or non-melanoma, skin cancer. It is also known as rodent ulcer and basalioma. Patients with BCC often develop multiple primary tumours over time.

Who gets basal cell carcinoma?

Risk factors for BCC include:

What causes basal cell carcinoma?

The cause of BCC is multifactorial.

What are the clinical features of basal cell carcinoma?

BCC is a locally invasive skin tumour. The main characteristics are:

BCC is very rarely a threat to life. A tiny proportion of BCCs grow rapidly, invade deeply, and/or metastasise to local lymph nodes.

Types of basal cell carcinoma

There are several distinct clinical types of BCC, and over 20 histological growth patterns of BCC.

Nodular BCC

Nodular basal cell carcinoma Nodular basal cell carcinoma Nodular basal cell carcinoma Nodular basal cell carcinoma
Nodular basal cell carcinoma

Superficial BCC

Basal cell carcinoma Superficial basal cell carcinoma Superficial basal cell carcinoma Superficial basal cell carcinoma
Superficial basal cell carcinoma

Morphoeic BCC

Morphoeic basal cell carcinoma Morphoeic basal cell carcinoma Morphoeic basal cell carcinoma Morphoeic basal cell carcinoma
Morphoeic basal cell carcinoma

Basisquamous BCC

Basal cell carcinoma Basisquamous  cell carcinoma Basisquamous  cell carcinoma
Basisquamous BCC

Fibroepithelial tumour of Pinkus

More images of basal cell carcinoma ...

Complications of basal cell carcinoma

Recurrent BCC

Recurrence of BCC after initial treatment is not uncommon. Characteristics of recurrent BCC often include:

Basal cell carcinoma recurrent after PDT
After PDT
Basal cell carcinoma recurrent after curettage and electrosurgery
After superficial surgery
Basal cell carcinoma recurrent after topical fluorouracil
After fluorouracil
Basal cell carcinoma recurrent after imiquimod
After imiquimod
Recurrent basal cell carcinoma

Advanced BCC

Advanced BCCs are large, often neglected tumours.

Metastatic BCC

How is basal cell carcinoma diagnosed?

BCC is diagnosed clinically by the presence of a slowly enlarging skin lesion with typical appearance. The diagnosis and histological subtype is usually confirmed pathologically by a diagnostic biopsy or following excision.

Some typical superficial BCCs on trunk and limbs are clinically diagnosed and have non-surgical treatment without histology.

What is the treatment for primary basal cell carcinoma?

The treatment for a BCC depends on its type, size and location, the number to be treated, patient factors, and the preference or expertise of the doctor. Most BCCs are treated surgically. Long-term follow-up is recommended to check for new lesions and recurrence; the latter may be unnecessary if histology has reported wide clear margins.

Excision biopsy

Excision means the lesion is cut out and the skin stitched up.

Mohs micrographically controlled excision

Mohs micrographically controlled surgery involves examining carefully marked excised tissue under the microscope, layer by layer, to ensure complete excision.

Superficial skin surgery

Superficial skin surgery comprises shave, curettage, and electrocautery. It is a rapid technique using local anaesthesia and does not require sutures.

Cryotherapy

Cryotherapy is the treatment of a superficial skin lesion by freezing it, usually with liquid nitrogen.

Photodynamic therapy

Photodynamic therapy (PDT) refers to a technique in which BCC is treated with a photosensitising chemical, and exposed to light several hours later.

Imiquimod cream

Imiquimod is an immune response modifier.

Fluorouracil cream

5-Fluorouracil cream is a topical cytotoxic agent.

Radiotherapy

Radiotherapy or X-ray treatment can be used to treat primary BCCs or as adjunctive treatment if margins are incomplete.

What is the treatment for advanced or metastatic basal cell carcinoma?

Locally advanced primary, recurrent or metastatic BCC requires multidisciplinary consultation. Often a combination of treatments is used.

Targeted therapy refers to the hedgehog signalling pathway inhibitors, vismodegib and sonedegib. These drugs have some important risks and side effects.

How can basal cell carcinoma be prevented?

The most important way to prevent BCC is to avoid sunburn. This is especially important in childhood and early life. Fair skinned individuals and those with a personal or family history of BCC should protect their skin from sun exposure daily, year-round and lifelong.

Oral nicotinamide (vitamin B3) in a dose of 500 mg twice daily may reduce the number and severity of BCCs.

What is the outlook for basal cell carcinoma?

Most BCCs are cured by treatment. Cure is most likely if treatment is undertaken when the lesion is small.

About 50% of people with BCC develop a second one within 3 years of the first. They are also at increased risk of other skin cancers, especially melanoma. Regular self-skin examinations and long-term annual skin checks by an experienced health professional are recommended.

Related information

References:

On DermNet NZ:

Other websites:

Books:

See the DermNet NZ bookstore

Author: Honorary Associate Profesor Amanda Oakley, Dermatologist, Hamilton, New Zealand, 1997. Updated December 2015.



DermNet NZ does not provide an online consultation service.
If you have any concerns with your skin or its treatment, see a dermatologist for advice.